Search

Background: Endless loop tachycardia (ELT) is the commonest pacemaker mediated tachycardia (PMT) encountered among patients with cardiac implantable electronic devices (CIEDs). Despite being enabled with various preventive algorithms, we encountered several cases having recurrent, long, and symptomatic ELT. Materials and Methods: We retrospectively analyzed consecutive device checkups at device clinic at a single center of eastern India between January 2019 to March 2023. Results: There were 20 cases of confirmed and sustained ELT among 4520 device checks. Although mostly benign, in two cases ELT led to clinical worsening in patients having left ventricular (LV) systolic dysfunction. Even with good ventricular function, ELT resulted in improper atrioventricular (AV) synchrony leading to disabling symptom in one case. The differentiation of ELT from sinus tachycardia and atrial tachycardia (AT) was not always easy. Magnet application is certainly useful to differentiate. The situations that provoked ELT in this study were—long AV delays, VIP (ventricular intrinsic preferences)/MVP (managed ventricular pacing), atrial non‐capture, atrial under/over sensing, premature ventricular contractions (PVCs)/couplets, premature atrial contractions (PAC) and slower ventriculo‐atrial (VA) conduction. Rate responsive shortening of post‐ventricular atrial refractory period (PVARP) also promoted its occurrence and hindered troubleshooting. When ELT occurred despite post‐PVC extension of PVARP, lowering the atrial sensitivity, switching to bipolar sensing and manual setting of longer PVARP after measuring VA conduction time were useful. "Rate responsive PVARP" had to be turned off in a few cases to prevent ELT. On the contrary, an over aggressive prolongation of PVARP led to repetitive non‐reentrant ventriculo‐atrial synchrony (RNRVAS) in two cases. Checking VA conduction during implantation and noninvasive program stimulation (NIPS) during follow up were useful to check the tendency for ELT. Conclusion: Clinically significant ELT is rare but not uncommon among devices having in‐built preventive algorithms. Manual adjustments are often useful to troubleshoot the same. [ABSTRACT FROM AUTHOR]

The article offers information on the role of Empagliflozin Outcome Trial in Patients with Chronic Heart Failure and a Reduced Ejection Fraction. It mentions that empaglif1ozin was associated with a lower risk than placebo of a composite outcome of cardiovascular death or hospitalization for heart failure among patients who had heart failure with reduced ejection fraction.